Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver

Cells(2020)10.3390/cells9020452Source: DataRank Database

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver is a research paper published in Cells (2020). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.10)OA: goldTopics (77)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Ralf Weiskirchen ORCID,Thomas S. Weiß ORCID,Ute Schwinghammer,Martin Fritz ORCID,Torgom Seferyan ORCID

Live enrichment

PubMed:32089540 PMC:PMC7072823 OpenAlex:https://openalex.org/W3006576527

Interfaculty Centre for Pharmacogenomics and Pharma Research (ICEPHA) Graduate school Tuebingen-Stuttgart

Grant: given to L.D. and R.T.

NIH

Grant: Grant RO1 DK-56621 given to SLF

Austrian Science Fund FWF

Grant: P 31720

National Institutes of Health

Grant: 5R01DK056621-07

The Role of KLF6 in Hepatic Fibrosis

FWCI

1.10

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/9/2/452/pdf?version=1583051809

publisherhttps://www.mdpi.com/2073-4409/9/2/452/pdf?version=1583051809

publisherhttps://www.mdpi.com/2073-4409/9/2/452/pdf

journalhttps://doi.org/10.3390/cells9020452

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32089540

Fields of Study

Liver Disease Diagnosis and TreatmentAlzheimer's disease research and treatmentsLiver physiology and pathology0301 basic medicine03 medical and health sciencesAmyloid beta-PeptidesAnimalsDisease Models, AnimalFibrosisGene ExpressionHumansLiver CirrhosisMaleMiceMice, TransgenicMiddle AgedPeptide FragmentsRatsRats, Sprague-Dawley

MeSH Terms

AnimalsDisease Models, AnimalFibrosisHumansLiver CirrhosisMaleMice, TransgenicMiddle AgedPeptide FragmentsGene ExpressionAmyloid beta-PeptidesRats, Sprague-DawleyMiceRats

Keywords

CirrhosisHepatic stellate cellFibrosisAmyloid betaTransforming growth factor betaBiologyBlood–brain barrierEndocrinologyHepatic fibrosisGenetically modified mouseInternal medicinePathologyTransforming growth factorMedicineTransgeneCentral nervous systemDiseaseBiochemistryMyelin basic proteinHepatic stellate cellsLiver cirrhosisAstrocytesEndothelial nitric oxide synthasePresenilinAlzheimer’s diseaseNeprilysinLiver Sinusoidal Endothelial CellsBeta SecretaseLiver Sinusoidal PermeabilityMaleGene ExpressionMice, TransgenicArticleRats, Sprague-DawleyMiceAnimalsHumansAmyloid beta-PeptidesQH573-671Middle AgedPeptide FragmentsRatsDisease Models, AnimalCytology

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 0: Good health and well-being